Article Text

PDF
Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Dependence and psychosis with 4-methylmethcathinone (mephedrone) use
  1. N Bajaj1,
  2. D Mullen2,
  3. S Wylie2
  1. 1Department of General Adult Psychiatry, Falkirk Royal Infirmary, Falkirk, UK
  2. 2Eriskay House, Stobhill Hospital, Glasgow, UK
  1. Correspondence to N Bajaj, nbajaj{at}doctors.org.uk

Summary

‘Legal highs’ are recreational drugs sold over the internet and the so-called ‘head shops’ all over the UK. They are freely available to buy and use as they are not covered by the Misuse of Drugs Act 1971. Mephedrone (4-methylmethcathinone) was sold as a ‘legal high’ until 17 April 2010 when it was made a class B drug under the Misuse of Drugs Act 1971. Numerous deaths and self-harm has been associated with mephedrone use. Effects of mephedrone are reported to be empathogenic similar to 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and stimulant properties similar to cocaine. Not much is known of the effects of mephedrone on mental health. We present a case of dependence and psychosis in a patient using mephedrone (4-methylmethcathinone). The patient needed inpatient hospital care, was treated with antipsychotic olanzapine and recovered well.

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.